Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
AIBD Regionals April NC
Session I: State of the Art IBD Management in 2022
Complicated Crohn’s Disease in 2022
Saturday, April 2, 2022
9:30 AM – 9:50 AM
Speaker(s)
Uni Wong, MD
University of Maryland School of Medicine
Baltimore, Maryland
This session is supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Learning Objectives:
Describe the characteristics and typical prognosis for a patient with complex fistulizing CD
Assess the mechanisms of action of mesenchymal stem cell therapy in the treatment of fistulizing CD
Evaluate key efficacy and safety data from recent clinical trials evaluating mesenchymal stem cell therapy in the treatment of fistulizing CD